© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
March 26, 2018
First- and second-line treatment of clear cell RCC has changed dramatically, Dr. Eric Jonasch said during the NCCN Annual Conference in Orlando.
At the NCCN Annual Conference in Orlando, Dr. April Salama discussed targeted treatment options in first- and second-line therapy for advanced melanoma.